XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
Common Stock
Preferred Series A
Preferred Series B
Preferred Series C
Additional Paid-In Capital
Accumulated Deficit Accumulated
Non-Controlling Interest
Total
Beginning Balance, Shares at Dec. 31, 2017 892,044 4,817,792 850,000        
Beginning Balance, Amount at Dec. 31, 2017 $ 89 $ 482 $ 850 $ 1,527,254 $ (39,091,757) $ 397,856 $ (37,165,226)
Series B preferred dividend requirement (70,157) (70,157)
Net loss (2,699,163) 128,514 (2,570,649)
Ending Balance, Shares at Mar. 31, 2018 892,044 4,817,792 850,000        
Ending Balance, Amount at Mar. 31, 2018 $ 89 $ 482 $ 850 1,527,254 (41,861,077) 526,370 (39,806,032)
Beginning Balance, Shares at Dec. 31, 2018 17,763,469 481,780 50,000        
Beginning Balance, Amount at Dec. 31, 2018 $ 1,776 $ 48 $ 5 42,913,532 (52,115,183) (9,199,822)
Issuance of common shares for cash, net, Shares 1,170,200              
Issuance of common shares for cash, net, Amount $ 117       4,253,883     4,254,000
Issuance of common shares for services, Shares 159,000              
Issuance of common shares for services, Amount $ 16       1,672,200     $ 1,672,200
Issuance of common shares for asset acquisition, Shares 2,000,000             2,000,000
Issuance of common shares for asset acquisition, Amount $ 200       24,399,800     $ 24,400,000
Issuance of common shares for conversion of debt and accounts payable, Shares 4,417              
Issuance of common shares for conversion of debt and accounts payable       49,161     49,161
Issuance of warrants to consultants         2,385,000     2,385,000
Stock option expense         68,693     68,693
Issuance of common Shares for warrant Exercise, Shares 599,427              
Issuance of common Shares for warrant Exercise, Amount $ 60       (60)    
Conversion of Series A into common stock, Shares 1,605,934 (481,780)            
Conversion of Series A into common stock, Amount $ 161 $ (48)     (113)    
Conversion of Series C into common stock, Shares 13,750     (50,000)        
Conversion of Series C into common stock, Amount $ 1     $ (5) 4    
Net loss           (10,065,620)   (10,065,620)
Ending Balance, Shares at Mar. 31, 2019 23,316,197        
Ending Balance, Amount at Mar. 31, 2019 $ 2,331 $ 75,742,084 $ (62,180,803) $ 13,563,612